182 related articles for article (PubMed ID: 32997164)
1. Comparison of amide proton transfer imaging and magnetization transfer imaging in revealing glioma grades and proliferative activities: a histogram analysis.
Su C; Jiang J; Liu C; Shi J; Li S; Chen X; Ao Q
Neuroradiology; 2021 May; 63(5):685-693. PubMed ID: 32997164
[TBL] [Abstract][Full Text] [Related]
2. Amide proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas.
Wu M; Jiang T; Guo M; Duan Y; Zhuo Z; Weng J; Xie C; Sun J; Li J; Cheng D; Liu X; Du J; Zhang X; Zhang Y; Liu Y
Eur Radiol; 2024 May; 34(5):2986-2996. PubMed ID: 37855851
[TBL] [Abstract][Full Text] [Related]
3. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
[TBL] [Abstract][Full Text] [Related]
4. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.
Su C; Liu C; Zhao L; Jiang J; Zhang J; Li S; Zhu W; Wang J
AJNR Am J Neuroradiol; 2017 Sep; 38(9):1702-1709. PubMed ID: 28729292
[TBL] [Abstract][Full Text] [Related]
5. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
[TBL] [Abstract][Full Text] [Related]
6. Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI).
Su C; Zhao L; Li S; Jiang J; Cai K; Shi J; Yao Y; Ao Q; Zhang G; Shen N; Hu S; Zhang J; Qin Y; Zhu W
Eur Radiol; 2019 Mar; 29(3):1203-1210. PubMed ID: 30105412
[TBL] [Abstract][Full Text] [Related]
7. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.
Zou T; Yu H; Jiang C; Wang X; Jiang S; Rui Q; Mei Y; Zhou J; Wen Z
NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29098732
[TBL] [Abstract][Full Text] [Related]
8. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
[TBL] [Abstract][Full Text] [Related]
9. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
[TBL] [Abstract][Full Text] [Related]
10. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
[TBL] [Abstract][Full Text] [Related]
11. Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic contrast-enhancement, diffusion-weighted images, and MR spectroscopy.
Seo M; Choi Y; Soo Lee Y; Ahn KJ; Kim BS; Park JS; Jeon SS
Eur J Radiol; 2023 Aug; 165():110888. PubMed ID: 37257338
[TBL] [Abstract][Full Text] [Related]
12. Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.
Liu W; Wang X; Xie S; Liu WV; Masokano IB; Bai Y; Chen J; Zhong L; Luo Y; Zhou G; Li W; Pei Y
Cancer Imaging; 2023 Sep; 23(1):80. PubMed ID: 37658446
[TBL] [Abstract][Full Text] [Related]
13. Predicting O6-Methylguanine-DNA Methyltransferase Protein Expression in Primary Low- and High-Grade Gliomas Using Certain Qualitative Characteristics of Amide Proton Transfer-Weighted Magnetic Resonance Imaging.
Su L; Gao P; Lin S; Wu B; Qin W; Lin Y; Xue J
World Neurosurg; 2018 Aug; 116():e814-e823. PubMed ID: 29803064
[TBL] [Abstract][Full Text] [Related]
14. Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
Schön S; Cabello J; Liesche-Starnecker F; Molina-Romero M; Eichinger P; Metz M; Karimov I; Preibisch C; Keupp J; Hock A; Meyer B; Weber W; Zimmer C; Pyka T; Yakushev I; Gempt J; Wiestler B
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1468-1475. PubMed ID: 31953672
[TBL] [Abstract][Full Text] [Related]
15. Three-Dimensional Gradient-Echo-Based Amide Proton Transfer-Weighted Imaging of Brain Tumors: Comparison With Two-Dimensional Spin-Echo-Based Amide Proton Transfer-Weighted Imaging.
Murayama K; Ohno Y; Yui M; Yamamoto K; Ikedo M; Ohba S; Hanamatsu S; Iwase A; Ikeda H; Hirose Y; Toyama H
J Comput Assist Tomogr; 2023 May-Jun 01; 47(3):494-499. PubMed ID: 37185016
[TBL] [Abstract][Full Text] [Related]
16. Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
Yu H; Wen X; Wu P; Chen Y; Zou T; Wang X; Jiang S; Zhou J; Wen Z
Eur Radiol; 2019 Oct; 29(10):5298-5306. PubMed ID: 30887206
[TBL] [Abstract][Full Text] [Related]
17. Amide proton transfer weighted imaging in pediatric neuro-oncology: initial experience.
Obdeijn IV; Wiegers EC; Alic L; Plasschaert SLA; Kranendonk MEG; Hoogduin HM; Klomp DWJ; Wijnen JP; Lequin MH
NMR Biomed; 2024 Jun; 37(6):e5122. PubMed ID: 38369653
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
Durmo F; Rydhög A; Testud F; Lätt J; Schmitt B; Rydelius A; Englund E; Bengzon J; van Zijl P; Knutsson L; Sundgren PC
PLoS One; 2020; 15(12):e0244003. PubMed ID: 33373375
[TBL] [Abstract][Full Text] [Related]
19. Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T.
Friismose AI; Markovic L; Nguyen N; Gerke O; Schulz MK; Mussmann BR
Radiography (Lond); 2022 Feb; 28(1):95-101. PubMed ID: 34509365
[TBL] [Abstract][Full Text] [Related]
20. Repeatability of amide proton transfer-weighted signals in the brain according to clinical condition and anatomical location.
Lee JB; Park JE; Jung SC; Jo Y; Kim D; Kim HS; Choi CG; Kim SJ; Kang DW
Eur Radiol; 2020 Jan; 30(1):346-356. PubMed ID: 31338651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
